NCT04004390View on ClinicalTrials.gov

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

June 28, 2019

Primary Completion Date

December 1, 2019

Study Completion Date

December 30, 2019

Conditions
Post-Poliomyélitis Syndrom
Trial Locations (1)

34295

Uh Montpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04004390 - Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin | Biotech Hunter | Biotech Hunter